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SAINT LOUIS UNIVERSITY SCHOOL OF LAW

EMERGING AND TRANSITIONING COUNTRIES’
ROLE IN GLOBAL HEALTH
JENNIFER PRAH RUGER, Ph.D.* AND NORA Y. NG, Ph.D.**
I. INTRODUCTION
Global health scholarship has failed to adequately consider the “BRIC”
cluster of nations—Brazil, Russia, India and China—particularly in the
aggregate. An article search with the keywords “BRIC” and “public health”
yields just one publication. But these countries have a unique role to play in
the global health enterprise by addressing global health problems as they
build their own health systems and help developing countries improve their
populations’ health. Moreover, the BRIC nations are becoming increasingly
important components of the global health architecture, individually as
nations and collectively as a nexus of influence. In June 2009, the countries
held the first-ever BRIC summit in Yekaterinburg, Russia, debuting as a
policy consultation and coordination group.1
What these countries collectively have to offer in the quest to improve
global health merits attention. This article focuses on the role of emerging
and transitioning countries as actors in (1) providing financial assistance to
lower-income countries; (2) supplying medical goods and services to the
developing world; (3) giving technical assistance; (4) improving access to
medicines and intellectual property; (5) modeling effective health-sector
framework-building to less developed countries; (6) delivering object lessons
learned from the health and development process; (7) helping lower-income
countries grow their economies and reduce poverty; (8) taking a significant

* Associate Professor at Yale University at the Schools of Public Health, Medicine, and
Graduate School of Arts and Sciences and Adjunct faculty at the Law School. A previous
version of this paper, entitled “Public Health and Emerging Risks: Emerging Countries’
Responsibility and International Cooperation,” was presented at the High Level Workshop on
Development Assistance, 7-8 March 2007, European Investment Bank, Luxembourg. Thanks
go to participants at that meeting for their comments and to Betsy Rogers for her editing
assistance. This research was supported, in part, by the Institute for Sustainable Development
and International Relations and the Whitney and Betty MacMillan Center for International and
Area Studies.
** Research assistant to Professor Ruger.
1. Tony Halpin, Brazil, Russia, India and China Form Bloc to Challenge U.S. Global
Dominance, TIMES, June 17, 2009, at 33.
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role in global health governance; and (9) bolstering the link between health
and foreign policy. For all their growing power and potential, however, they
are still emerging and transforming countries with their own daunting and
persisting health challenges that require continuing assistance from the
global health community.
II. POTENTIAL BRIC CONTRIBUTIONS TO THE GLOBAL HEALTH ENTERPRISE

A. Providing Financial Assistance
Given their growing financial resources,2 emerging countries have a
rightful role in providing financial assistance to developing countries.
Emerging countries invest in health care, public health, and disease-specific
programs in developing countries.3 India, for example, has financed
Human Immunodeficiency Virus (“HIV”) and Acquired Immune Deficiency
Syndrome (“AIDS”) programs in several African countries.4
Indian
pharmaceutical companies have built production facilities in Africa and Latin
America, playing a “pivotal” role in lowering the prices of antiretroviral
drugs to affordable levels in developing countries,5 while also expanding
jobs and economic development.
The existing international development architecture leaves gaps in health
system development. Emerging countries, in conjunction with international
organizations, can help fill the gaps by raising awareness and advocating
for financial assistance. In 2004, for instance, the president of Brazil, Lula
da Silva, along with Chile, France, and then-UN Director-General Kofi
Annan, called for a “global political alliance” to support a global fund for
hunger and poverty.6 At their 2009 summit, BRIC issued a statement on
global food security calling for financial and technical support in food
production, the sustainability of biofuels use and production, and the
reduction of agricultural subsidies.7 In May 2010, BRIC agricultural
ministers signed a global food security declaration, with the aims of

2. Id. (stating that the BRIC nations represent forty percent of the world’s population and
fifteen percent of the world’s gross domestic product).
3. See infra notes 4-5, 15-16, 20-21, 23 and accompanying text (illustrating examples
of emerging countries investing in developing countries).
4. J. STEPHEN MORRISON & JENNIFER KATES, CTR. FOR STRATEGIC & INT’L STUDIES (CSIS) &
KAISER FAMILY FOUND., THE G-8, RUSSIA’S PRESIDENCY, AND HIV/AIDS IN EURASIA: A REPORT TO
THE CSIS TASK FORCE ON HIV/AIDS IN COLLABORATION WITH THE KAISER FAMILY FOUNDATION 4
(2006), available at http://csis.org/files/media/csis/pubs/060614_g8aids.pdf, at 4.
5. Id.
6. John Zarocostas, Brazil Drives Efforts to Fight Hunger and Poverty, 363 LANCET 462,
462 (2004).
7. President of Russia Official Web Portal, BRIC’s Joint Statement on Global Food
Security (June 16, 2009), http://archive.kremlin.ru/eng/text/docs/2009/06/217964.shtml.
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developing a strategy to ensure food access for vulnerable populations,
creating an agriculture information system, adapting to climate change, and
improving agricultural technological innovation and cooperation.8
BRIC nations are prosperous enough to have transitioned to “donor”
status in international development assistance. All four BRIC countries are
donors to The Global Fund.9 India became the fifteenth largest donor to
the World Food Program in 2005, and in 2004 lent more than $400
million in hard currency to Brazil, Burundi, and Indonesia, under the
Financial Transactions Plan of the IMF.10 Russia has also provided bilateral
foreign assistance to a number of countries, including Cuba, Iran,
Chechnya, Kyrgyzstan, Iraq, China, Lebanon, Palestine, Afghanistan, Serbia,
and Iceland, though the bulk of this assistance is for economic or
geopolitical reasons and not for public health.11 China, too, gives aid to
African countries in the form of debt write-offs, preferential loans, buyer’s
credit, investment, training, and building of infrastructure, with the declared

8. Michael Lucivero, BRIC Ministers Sign Global Food Security Pact (Apr. 5, 2010).
http://foodcrisis.foreignpolicyblogs.com/2010/04/05/bric-countries-sign-food-security-pact/.
9. The Global Fund, The Global Fund’s Donor Governments, http://www.theglobal
fund.org/en/donors/list/ (last visited Sep. 2, 2010). China, India, and Russia are listed as
current donors in the Second Replenishment Cycle 2008-2010, and Brazil is listed as having
contributed previously.
10. Dweep Chanana, India as an Emerging Donor, 44 ECON. & POL. WEEKLY 11, 12
(2009).
11. Megan K. Stack, Hillary Clinton, Russians Clash Publicly Over Iran Reactor, L.A.
TIMES, Mar. 19, 2009, http://articles.latimes.com/2010/mar/19/world/la-fg-clinton-russia192010 mar19 (Russia involved in building Iran’s nuclear power plant); Conor Sweeney & Oleg
Shchedrov, Russia Offers Allies Aid as U.S. Base Ordered Shut, REUTERS, Feb. 3, 2009,
http://www.reuters.com/article/idUSTRE51227720090203 (Russia gave aid packages worth
$150 and $354 million to Kyrgyzstan and Cuba, respectively); Iceland Turns to Russia for
Bailout, RIA NOVOSTI, Oct. 10, 2008, http://en.rian.ru/analysis/20081010/117659587.html
(Russia bails out Iceland by granting “huge stabilization loan at an unbelievably low interest
rate”); Russia’s Aid to Quake-Hit China Totaled $14 Million, RIA NOVOSTI, July 16, 2008,
http://en.rian.ru/world/20080716/114099714.html; Russia May Continue Giving Aid to
Palestine—Foreign Ministry, RIA NOVOSTI, May 8, 2006, http://en.rian.ru/russia/20060508/
47870322.html (Russia provided $10 million to Palestine for social and humanitarian needs);
Russia Offers Afghanistan Aid in Establishing Political System, RIA NOVOSTI, June 15, 2009,
http://en.rian.ru/russia/20090615/155259203.html; Russia Promise on Chechnya Aid, BBC
NEWS, Jan. 28, 2000, http://news.bbc.co.uk/2/hi/europe/621724.stm; Russia Proposes Aid
to Lebanon to Rebuild Infrastructure, RIA NOVOSTI, Sep. 7, 2006, http://en.rian.ru/russia/
20060907/53602293.html; Russia Sends Humanitarian Aid to Iraq, CHINA VIEW, Dec. 25,
2004, http://news.xinhuanet.com/english/2004-12/25/content_2380273.htm (Russia sent
tents, blankets, heating appliances, lighting appliances, medicine, medical equipment, and
antiseptics to Iraq as humanitarian aid); Third Plane with Russian Humanitarian Aid Lands in
Serbia, RIA NOVOSTI, Apr. 8, 2008, http://en.rian.ru/russia/20080408/104031974.html.
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goal of “mutual” economic benefit.12 At the BRIC summit, Chinese
President Hu Jintao offered ten billion dollars of credit support to the
countries of Central Asia to help deal with the global economic recession.13
While observers have noted that “China’s health sector is overwhelmingly
internally focused,”14 China does undertake some medical financial aid in
Africa.15 According to a 2006 report by China’s official press agency, the
Chinese government planned to build thirty hospitals and thirty malaria
prevention and treatment demonstration centers, and to provide about
$37.5 million in grants for anti-malarial drugs.16 Although most of Russian
and Chinese foreign aid does not currently directly target health, it does
suggest that these emerging countries are in position to provide healthrelated financial assistance if health becomes a larger part of their foreign
policy agenda.
Indian foreign financial aid is similar to China’s in that it tends to be
oriented toward the economy and trade. As a donor, it has been remarked
that India appears in another country “only when it is also an investor, trade
partner or political ally, or can become one.”17 India has a long-standing
practice of economic and military aid in South Asia—it funds almost sixty
percent of Bhutan’s budget, and gives aid and loans to Afghanistan, Nepal,
and Myanmar.18 Partly in competition with China, India has branched out
to Africa. In 2009, India doubled the amount set aside for loans to Africa
to $5.2 billion, and Africa is now one of the largest recipients of Indian
development assistance.19 However, some of India’s financial aid does go
toward health purposes such as HIV/AIDS.20
Health plays a more prominent part in Brazilian foreign financial
assistance. In 2007, it was estimated that Brazil spent around $120 million
worldwide on HIV/AIDS relief programs, the rehabilitation of former
combatants, and other areas such as agricultural development and
12. Chinese Aid Flows into Africa, VOANEWS.COM, May 8, 2007, http://www1.voanews.
com/english/news/africa/a-13-Chinese-Aid-Flows-into-Africa.html.
13. Guy Faulconbridge, Developing World Leaders Show New Power at Summits,
REUTERS, June 16, 2009, http://www.reuters.com/article/idUSTRE55F02F20090616?feed
Type=RSS&feedName=topNews.
14. Qide Han et al., China and Global Health, 372 LANCET 1439, 1439 (2008).
15. Id.
16. China, Africa Vow Closer Cooperation in Fighting HIV/AIDS: Action Plan, PEOPLE’S
DAILY ONLINE, Nov. 6, 2006, http://english.peopledaily.com.cn/200611/06/eng20061106_
318575.html.
17. MATTHIAS JOBELIUS, NEW POWERS FOR GLOBAL CHANGE? CHALLENGES FOR THE
INTERNATIONAL DEVELOPMENT COOPERATION: THE CASE OF INDIA 2 (FRIEDRICH EBERT STIFTUNG,
2007), available at http://library.fes.de/pdf-files/iez/global/04718.pdf.
18. Chanana, supra note 10, at 11.
19. Id. at 12.
20. MORRISON & KATES, supra note 4.
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vocational training.21 Brazil’s largest beneficiaries include Paraguay, East
Timor, Haiti, Mozambique, Angola, and Guinea-Bissau.22 Financial aid
also contributes to infrastructure development, such as the building of a
pharmaceutical laboratory for the production of antiretroviral drugs in
Mozambique.23

B.

Supplying Medical Goods and Services

Besides financial aid, emerging countries can supply necessary medical
goods and services, both by directly exporting to developing countries and
exemplifying the usefulness of domestic generic drug industries. For
example, Brazil has developed a significant generic drug industry that has
helped the government in its attempt to provide free antiretroviral (“ARV”)
medications to all individuals who need them.24 Both India and China
manufacture raw chemicals and ingredients for drug manufacturing, and
both are major manufacturers of generic drugs, including ARVs, for
domestic use and international export.25 In fact, Brazil purchases active
pharmaceutical ingredients from India and China and then domestically
produces ARVs for its own population.26 India especially is an important
source of ARVs for countries that cannot produce their own.27 It is also
branching out to make other complex medications (such as for cancer) and
undertaking pharmaceutical research and development.28
Drugs are not the only exported medical supply. India’s Aravind Eye
Care System, for instance, produces intraocular lenses used in cataract

21. CATRINA SCHLÄGER, NEW POWERS FOR GLOBAL CHANGE? CHALLENGES FOR THE
INTERNATIONAL DEVELOPMENT COOPERATION: THE CASE OF BRASIL 6 (FRIEDRICH EBERT STIFTUNG,
2007), available at http://www.nuso.org/upload/fes_pub/schlager.pdf.
22. José Soares Jr., Brazil as a South-South Cooperation Partner, in IT’S TIME FOR BRAZIL IN
SINGAPORE 50, 51-52 (Tatiana Rosito ed., 2008), available at http://www.brazil.org.sg/

Download/brazil08.pdf.
23. Eduardo J. Gómez, Brazil’s Blessing in Disguise, FOREIGN POL., July 22, 2009,
http://www.foreignpolicy.com/articles/2009/07/22/brazils_blessing_in_disguise (last visited
Sep. 2, 2010).
24. Jon Cohen, Ten Years After, 313 SCIENCE 484, 484 (2006).
25. CHERI GRACE, THE EFFECT OF CHANGING INTELLECTUAL PROPERTY ON PHARMACEUTICAL
INDUSTRY PROSPECTS IN INDIA AND CHINA: CONSIDERATIONS FOR ACCESS TO MEDICINES 14
(2004), http://www.dfidhealthrc.org/publications/atm/Grace2.pdf.
26. Cohen, supra note 24, at 484, 487.
27. Grace, supra note 25, at 14-15.
28. Heather Timmons, India Expands Role as Drug Producer, N.Y. TIMES, July 6, 2010,
http://www.nytimes.com/2010/07/07/business/global/07indiadrug.html; Sachin Chaturvedi,

Emerging Indian Entrepreneurship in Biotechnology and National Innovation System:
Exploring Linkages and Prospects, 5 INT. J. TECHNOL & GLOBAL. 76 (2010).
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surgery through its own Aurolab facility.29 Producing its own lenses allowed
Aravind to cut lens costs from $200 to less than ten dollars, and Aurolab
lenses are now exported through various NGO partners and distribution
venues to more than one hundred countries, making up ten percent of the
global market.30
Services are exportable too; BRIC’s export is an increasingly important
short-term remedy to fill gaps in human resources for health and to address
the brain-drain problem in many countries. Russia has been active in
staffing select African HIV programs31 and has sent doctors and supplies to
disaster areas like Haiti and Chile in the wake of their recent devastating
earthquakes.32 China, as part of its diplomatic engagement with Africa,
provides medical supplies free of charge to some African countries, and
runs training programs for diseases including malaria and HIV/AIDS.33
Since 1964, China has “cumulatively sent over 15,000 doctors to more
than 47 African countries and treated approximately 180 million African
patients[.]”34 The recipient African countries pay the costs of these medical
teams, but for the poorest recipients China covers the teams’ travel costs
and the supplies the teams bring along.35
Even countries without BRIC’s growing economic and financial heft can
provide important medical services. Cuba is an exporter of medical aid.36
Cuban health assistance programs have sent teams of doctors to disaster
areas such as Haiti after Hurricane Mitch in 1998 and to Pakistan after the
earthquake in 2005.37 Cuban doctors can be found working in remote and
underserved areas in countries like Honduras,38 Belize,39 and Equatorial

29. Aman Bhandari et al., Specialty Care Systems: A Pioneering Vision for Global Health,
27 HEALTH AFF. 964, 970 (2008).
30. Id.
31. MORRISON & KATES, supra note 4, at 4.
32. Russian Humanitarian Aid Arrives in Quake-Hit Chile, RIA NOVOSTI, Mar. 5, 2010,
http://en.rian.ru/russia/20100305/158097559.html; Russia to Send Two More Aid Planes to
Quake-Hit Haiti, RIA NOVOSTI, Jan. 31, 2010, http://en.rian.ru/russia/20100131/15773040
7.html.
33. Drew Thompson, China’s Soft Power in Africa: From the “Beijing Consensus” to
Health Diplomacy, CHINA BRIEF, Oct. 13, 2005, http://www.jamestown.org/programs/china
brief/single/?tx_ttnews%5Btt_news%5D=30973&tx_ttnews%5BbackPid%5D=195&no_cache
=1.
34. Id.
35. Id.
36. Hernando Calvo Ospina, Havana’s Medics Work Around the World; Cuba Exports
Health, LE MONDE DIPLOMATIQUE, Aug. 2006, http://mondediplo.com/2006/08/11cuba.
37. Id.
38. Id.
39. Michael Voss, Cuba Pushes Its ‘Medical Diplomacy’, BBC NEWS, May 20, 2009,
http://news.bbc.co.uk/go/pr/fr/-/2/hi/americas/8059287.stm.
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Guinea.40 Patients also go to Cuba from Latin America and the Caribbean
for free cataract surgery, courtesy of the Cuban government.41 Possibly the
most acclaimed medical service Cuba provides is through its medical
schools, especially its Latin American Medical School, which trains students
from mainly Latin American, Caribbean, and African countries.42 Cuba
grants these students full scholarships, on condition that they return to their
home countries to work once they qualify as doctors.43 Supplying medical
services to other developing countries has been an effective diplomatic
strategy for Cuba, helping it develop positive ties around the world despite
political isolation by the United States.44 It is also a part of Cuban trade.
Venezuela, for example, subsidizes oil to Cuba in return for the 20,000
The Cuban example
Cuban medical professionals working there.45
highlights diplomatic and economic rationales for emerging countries to
expand their provision of medical supplies and services, and may serve as a
model for that expansion.
Other emerging countries serve as regional training centers for scientists
and researchers as well. Brazilian universities and institutions train scientists
from other South American countries, while many African scientists receive
education in Nigeria, Kenya, and Mali.46 Malaysia, Thailand, and the
Philippines also train Asian and African researchers, with special emphasis
on epidemiology.47

C. Providing Technical Assistance
In addition to medical goods and services, emerging nations can—and
do—provide technical assistance. Brazil created a network with seven other
middle-income countries to share technology and best practices regarding
the manufacture of pharmaceuticals.48 Brazil has also furnished technical
assistance to developing countries through the Brazil+7 initiative, an
alliance between UNICEF, UNAIDS, the Brazilian government, and seven

40. Marion Lloyd, A Medical School in Cuba Trains Doctors for Poor Countries, CHRON.
HIGHER EDUC., July 20, 2001, at A35.
41. Voss, supra note 39.
42. Lloyd, supra note 40.
43. Voss, supra note 39.
44. Id.
45. Id. (“Medical aid has become a ‘service export.’”).
46. Thomas C. Nchinda, Research Capacity Strengthening in the South, 54 SOC. SCI. &
MED. 1699, 1708 (2002).
47. Id.
48. Susan Okie, Fighting HIV—Lessons from Brazil, 354 NEW ENG. J. MED. 1977, 1981
(2006) (Brazil, Argentina, China, Cuba, Nigeria, Russia, Ukraine, and Thailand are working
together to “improve each country’s capacity to manufacture medicines, condoms, and
laboratory reagents needed to fight AIDS . . . .”).
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other countries to increase access to antiretroviral medicine, particularly
those that prevent mother-to-child-transmission, in partner countries.49
Treatment programs in those countries have expanded as a result of this
initiative.50
China and India are also well placed to offer technical assistance. In
addition to China’s training sessions on malaria, HIV, and other diseases in
Africa, China and India may prove to be especially effective partners in
research and development. China is “ranked fourth internationally in 2005
for patents granted and publications in indexed journals,”51 indicative of its
strength in research. India’s human resources and advanced medical
expertise are also widely acknowledged, and it shows “great initiative and
commitment” in researching and developing HIV vaccines and
microbicides.52 To further this endeavor, India established the Global
Political Advocacy Initiative, which seeks to raise awareness and support for
an accelerated research and development effort for preventive HIV
vaccines.53
Technical assistance is not confined to medications. India’s Pan African
E-Network project is set up to provide digital information services, with an
emphasis on tele-education and tele-medicine, and its Africa-India
Framework for Cooperation aims to build capacity for medical professionals
to deal with pandemics.54 China has given billions in concessional loans to
African countries to further trade, but also to assist in areas such as health
and medical care.55
Other emerging countries likewise engage in South-South cooperation.
A health information system developed in South Africa was transferred to the
neighboring country Mozambique, which shares similarities in health system
structure.56 The “physical proximity and feeling of shared interest ease[d]

49. UNICEF, Saving Lives: “Brazil+7 South-South Cooperation”, http://www.unicef.org/
brazil/english/newsline2.htm (last visited Sep. 2, 2010) (The other countries are Sao Tome
and Principe, Bolivia, Paraguay, Cape Verde, Guinea-Bissau, East Timor, and Nicaragua.).
50. Id.
51. Zhu Chen, Biomedical Science and Technology in China, 372 LANCET 1441, 1442
(2008).
52. MORRISON & KATES, supra note 4, at 20.
53. Id.
54. Thalif Deen, China, India Lead South-South Cooperation, INTER PRESS SERVICE NEWS
AGENCY, Nov. 24, 2009, http://ipsnews.net/news.asp?idnews=49398.
55. Id.
56. Jens Kaasbøll & Jose Leopoldo Nhampossa, Transfer of Public Sector Information
Systems Between Developing Countries: South-South Cooperation (unpublished manuscript
presented at the International Federation for Information Processing Working Group 9.4
Conference on Social Implications of Computers in Developing Countries, May 29-31, 2002,
Bangalore, India), http://heim.ifi.uio.no/~jensj/TransferSouthSouth.pdf.
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the cooperation between the original developers and the adapters.”57 Egypt
has a Fund for Technical Cooperation with Africa (“EFTCA”), which finances
and organizes projects such as sending engineers to train workers in
Cameroon in medical equipment maintenance.58 Egypt also operates other
technical cooperation programs that target Central Asian and Islamic
countries.59 Bilateral provision of technical assistance is not the only
approach. Emerging countries are partnering with each other in “trilateral
cooperation” to provide technical assistance to developing countries.60
Egypt and Turkey cooperate to train Africans in fields like health, agriculture,
and security.61 Argentina works with PAHO/WHO to offer technical
assistance in endeavors such as polio eradication in the Nigerian child
population and to strengthen capacity relating to organ transplants in
Paraguay.62

D. Improving Access to Medicines and Intellectual Property
Emerging countries have begun to claim another critical role in
improving health—acting in blocs to negotiate intellectual property (“IP”)
regulations and access to medicines. Their potential for influence is a topic
of significant discussion and speculation.63 The expectation is that BRIC
nations—or individual countries anchoring other coalitions—could bargain
for more favorable application of intellectual property rights within the
World Trade Organization (“WTO”) and other international trade venues,
thereby improving access to essential medicines both for their own
populations and for those in other needy countries. Such collective
strategies are already beginning to play out. In 2005, for example, Brazil
reached an agreement between eleven Latin American governments and

57. Id. at 12.
58. INSouth.org, Egypt, http://www.insouth.org/index.php?option=com_content&view=
article&id=67:egypt&catid=31:country-windows&Itemid=86 (last visited Sep. 2, 2010).
59. Id. (Egyptian Fund for Technical Cooperation with Commonwealth and Trilateral
Cooperation on South-South Basis with Islamic Development Bank).
60. Id. (Trilateral Cooperation on South-South Basis with Islamic Development Bank and
Trilateral Cooperation on South-South Basis with Turkey).
61. Id.
62. PAN-AMERICAN HEALTH ORGANIZATION, SOUTH-SOUTH COOPERATION: TRIANGULAR
COOPERATION EXPERIENCE BETWEEN THE GOVERNMENT OF THE ARGENTINE REPUBLIC AND THE PANAMERICAN HEALTH ORGANIZATION/WORLD HEALTH ORGANIZATION 14-16 (2009), http://new.
paho.org/arg/images/coopSURSUR/css_ing.pdf.
63. See, e.g., Peter K. Yu, Access to Medicines, BRICS Alliances, and Collective Action,
34 AM. J.L. & MED. 345, 355, 358 (2008) (speculating that BRIC countries are “likely to play
an important role in the development of the international intellectual property regime” and
“there is no doubt that BRIC[] countries will be economically powerful in the future”).
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twenty-six drug companies to lower the prices of HIV/AIDS drugs in the
region.64
Even without traditional political alliances, the actions and successes of
BRIC countries in expanding drug access and IP rights can change norms
and expectations for global actors. In 2001, at the behest of several
pharmaceutical firms, the United States planned to bring WTO action
against Brazil and its drug patent laws.65 Brazil was able to mount effective
diplomatic and public relations campaigns to lobby the Bush administration
and to bring international attention to its “fight for life.”66 Washington
relented in the face of international pressure and a “potential public
In another instance, thirty-nine pharmaceutical
relations disaster.”67
companies sued the South African government to block the country from
importing generic anti-retroviral drugs,68 but they dropped the suit in 2001
due to negative international opinion.69 BRIC countries have sufficient
resources to respond actively to threats of IP-related trade sanctions and
lawsuits—China in particular has the economic clout to play hardball and
threaten countersanctions in trade negotiations, especially vis a vis the
United States.70 These actions also have some beneficial repercussions for
other developing countries. The Brazilian and South African episodes
helped raise international awareness and revealed widespread normative
expectations about essential drug access for the developing world. The
potential for hugely negative public relations from IP actions became
abundantly clear to pharmaceutical companies. At the very least, these
lessons make them unlikely to take another developing country to court.71
Drug companies may also try to garner positive publicity by donating or
discounting drugs to poor nations, thus more directly increasing access.72
Some emerging countries are taking more active and assertive measures
to increase drug access. Trade-related aspects of intellectual property rights
64. Okie, supra note 48, at 1981.
65. Roy Wadia, Brazil’s AIDS Policy Earns Global Plaudits, INTERNATIONALREPORTING
PROJECT.ORG, June 1, 2001, http://www.internationalreportingproject.org/stories/detail/820/.
66. Id.
67. Id.
68. Robert C. Bird & Daniel R. Cahoy, The Emerging BRIC Economies: Lessons from
Intellectual Property Negotiation and Enforcement, 5 NW. J. TECH. & INTELL. PROP. 400, 40708 (2007).
69. Ofeibea Quist-Arcton, South Africa: Drugs’ Giants Drop Case Against South Africa,
ALLAFRICA.COM, Apr. 19, 2001, http://allafrica.com/stories/200104190053.html
70. Bird & Cahoy, supra note 68, at 410-11.
71. Gumisai Mutume, Health and ‘Intellectual Property’: Poor Nations and Drug Firms
Tussle Over WTO Patent Provisions, AFR. RECOVERY, June 2001, at 15.
72. See generally PHARMACEUTICAL RES. & MANUFACTURERS OF AM. (PHRMA), GLOBAL
PARTNERSHIPS: HUMANITARIAN PROGRAMS OF THE PHARMACEUTICAL INDUSTRY IN DEVELOPING
NATIONS (2003).

SAINT LOUIS UNIVERSITY SCHOOL OF LAW

2010]

EMERGING AND TRANSITIONING COUNTRIES’ ROLE IN GLOBAL HEALTH

263

(“TRIPS”), a WTO agreement on intellectual property rights, permits
governments to allow would-be infringers to produce a patented product
through compulsory licenses if “reasonable commercial terms” cannot be
obtained from the right holder, or in case of “national emergency.”73
Countries have used compulsory licensing mainly as a negotiation tool—
threatening its use to get deeper drug discounts from pharmaceutical
firms.74 Brazil, which places great importance on the availability of
inexpensive ARV drugs, has made multiple threats to do so, but only actually
issued its first compulsory license in 2007, for Merck’s efavirenz.75 Thailand
is more aggressive. Thailand has issued compulsory licenses for two
antiretroviral drugs, efavirenz and lopinavir+ritonavir, which it has
repeatedly renewed.76 Thailand has acted partly to forestall an upsurge of
costs in its HIV/AIDS program from the impending failure of generic first-line
drugs—as the virus develops resistance, expensive patented second-line
drugs must be introduced.77 Some observers also think that Thai patent
seizures are a bid by Thailand to develop its generic drug industry into a
regional hub.78 Whatever Thailand’s reasons may be, countries like Bolivia
and Brazil have expressed support, and others, like the Philippines,
considered legislation to follow the Thai example.79 The move by middleincome countries to seize patents has been described as “a massive political
movement against intellectual property” that “seeks to make medicine into
public, not private, goods.”80

E.

Modeling Institutional Frameworks for Health

Institutional frameworks for health care and public health sectors
address the regulation of medical equipment, medicines, facilities, and
worksites; oversight of personnel training, licensing, and accreditation;
73. Mutume, supra note 71, at 14.
74. Id. at 15. (Brazil persuaded Merck to reduce the prices of two HIV/AIDS drugs by
threatening to permit compulsory licensing if it refused to make the drugs more accessible.)
75. Keith Alcorn, Brazil Issues Compulsory License on Efavirenz, AIDSMAP.COM, May 7,
2007, http://www.aidsmap.com/page/1427206/ (last visited Sep. 2, 2010); Ricardo Amaral,
Brazil Bypasses Patent on Merck AIDS Drug, ALERTNET.ORG, May 4, 2007, http://www.alert
net.org/thenews/newsdesk/N04351721.htm
76. Am. Univ. Wash. Coll. of Law, Program on Info. Justice & Intellectual Prop.,
Compulsory Licensing Controversy in Thailand, http://www.wcl.american.edu/pijip/thai_
comp_licenses.cfm (last visited Sep. 2, 2010).; Ed Silverman, Thailand Extends Compulsory
licenses on AIDS Meds, PHARMALOT.COM, Aug. 4, 2010, http://www.pharmalot.com/2010/
08/thailand-extends-compulsory-licenses-on-aids-meds/
77. George Wehrfritz, A New Kind of Drug War, NEWSWEEK, Apr. 9, 2007,
http://www.newsweek.com/id/35843.
78. Id.
79. Id.
80. Id.
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provision of hospitals, clinics, and health-related facilities; generation and
dissemination of health-related knowledge and information; and the
establishment of sustainable, equitable, and affordable health insurance
systems. The BRIC countries clearly have room for improvement in these
areas—they each lack sufficient facilities and supplies, and there have been
notorious lapses in the regulation of food and drug safety. China has had
numerous safety breaches, such as melamine in milk powders and pet food,
antifreeze chemical in toothpaste, and tainted heparin.81 In India, also,
investigations have uncovered repeated instances of inaccurate
dosage/duration in drug prescriptions, and even the lack of such
information altogether.82 Still, emerging countries offer some encouraging
examples for other countries to draw upon.
It would be hard to find a better instance of the development of an
institutional health care framework than the specialty care model in India.
India’s Aravind Eye Care System provides a particularly inspiring example of
the ways in which this specialty approach can build a system from the
ground up.83 The specialty care or “focused factory” model concentrates on
a particular medical condition, disease area, medication or procedure and
relies on standardized methods, management goals, core competencies,
and an efficient and specialized human capital base.84 The success of this
model has been attributed to four major features: “(1) implementation of
management systems that emphasize standardization and continuous
improvement; (2) the ability to attract and train specialized workforce; (3)
access to low-cost technology; and (4) generation of patient volume.”85
As of 2008, the Aravind Eye Care System has five hospitals with 3,950
beds and examines over two million patients annually.86 The attention to
standardized methods and specialized human resources with core
competencies is reflected in Aravind’s “serial production” approach.87
While an Aravind surgeon operates on one patient, the next patient is
prepared on the adjacent table. The surgeon simply swings his or her
surgical microscope over to the next table to begin the next procedure when
the surgeon is finished with the last one. Paramedical staff does simpler
tasks such as preparing patients and instruments, thus freeing the surgeon to
81. Gordon Fairclough & Loretta Chao, Chinese Formula Maker Hid Toxic Danger for
Weeks, WALL ST. J., Sep. 18, 2008, at A13, available at http://online.wsj.com/article/SB1221
66164382247931.html.
82. R. Sharma & B. Khajuria, Letter to Editor, Prescribing Practices of Doctors in Rural and
Urban India, 3 J. CLINICAL & DIAGNOSTIC RES. 1480, 1480-81 (2009).
83. Bhandari et al., supra note 29, at 967.
84. Id. at 964-965.
85. Id. at 965.
86. Id. at 967.
87. Id. at 968.
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concentrate on surgery alone.88 Standardized procedures and specialized
staff help maintain quality of care and enable high-volume patient
treatment. Aravind surgeons average around 2,000 cataract surgeries per
year, compared to the Indian national average of 250.89
The financing system set up by Aravind is progressive, with paying
patients subsidizing poor patients who receive low-cost or free care.90 As
mentioned earlier, Aravind’s Aurolab manufactures intraocular lenses
domestically, allowing huge reductions in costs as well as international
export.91 Aravind also established its own institute, Lions Aravind Institute of
Community Ophthalmology (“LAICO”), which pursues system-wide
improvements in “planning, efficiency, and effectiveness of all eye hospitals
in India.”92 India’s Cataract Blindness Control Program, a recognized
international public health success story, used Aurolab lenses and followed
the Aravind approach.93 Aravind has assisted eye hospitals in other
countries such as Bangladesh, Tanzania, and China.94 The He Eye Care
System in China, for instance, has emulated the Aravind model since
2001.95
Other examples of specialty care in India include the LifeSpring Hospital
System (a joint venture between the Acumen Fund and Hindustan Latex to
provide reproductive and pediatric care to low-income urban mothers and
their children); the Socjo Foundation (focused on training women in
communities to identify problems of low vision and sell low-cost eye
glasses); Jaipur Foot (locally-produced prosthetic limbs adapted for local
conditions); and the Medicine Shoppe (a leading pharmacy chain that sets
up healthcare clinics with attached pharmacies in low-income areas to
provide low-cost care and generic drugs).96 The Aravind and similar
approaches offer useful models for systems development in other countries,
although their transplantation should proceed with caution: there might well
be significant challenges in applying these systems to other contexts and
more complex areas of health.97

88.
89.
90.
91.
92.
93.

Id.
Id.
Id. at 967.
Id. at 970.
Id. at 968.

RUTH LEVINE & THE WHAT WORKS WORKING GROUP, CASE STUDIES IN GLOBAL HEALTH:
MILLIONS SAVED 139, 142 (2007).
94. Bhandari et al., supra note 29, at 971.
95. Id.
96. Id. at 966. See also Nadaa Taiyab, Medicine Shoppe: Bringing Health Services to
the Urban Poor, Acumenfund.org, June 2007, http://www.acumenfund.org/investment-story/
bringing-health-services-to-the-urban-poor.html (last visited Sep. 3, 2010)
97. Id. at 972-974.
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Beyond India, China may set an example for infectious disease reporting
and monitoring in its recently established China Information System for
Disease Control and Prevention (“CISDCP”). CISDCP is “the world’s largest
internet-based disease reporting system,” instituted since the SARS outbreak
in 2003.98 This system allows hospitals and clinics to report case-based
information on diseases immediately through the Internet, facilitating the
identification of outbreak locations and the cluster characteristics of patients
(e.g., age, sex, occupation) by health officials.99 In 2008, CISDCP
developed and integrated cellular phone reporting.100
Given the
increasingly potent threat of communicable diseases in a globalized
economy, strong nationally-based disease reporting systems are critical, and
combining what works best at the national level through an integrated
global system is an essential public health strategy for the twenty-first
century.
More active steps are being taken by emerging countries to develop and
shore up their health sector institutional framework. An instance of such a
step was the establishment of a Developing Countries’ Vaccine Regulators
Network (“DCVRN”) in 2004, under WHO auspices.101 The goal of
DCVRN is to strengthen regulatory capacity by facilitating discussion and
increasing exposure to procedures and policies for the evaluation of clinical
trial proposals and data through the exchange of information and expertise,
with the aim of generating guidelines and recommendations.102 The
founding members are Brazil, China, Cuba, India, Indonesia, South Korea,
Russia, South Africa, and Thailand, but DCVRN activities are to take into
account the needs of other developing countries that may request help from
the network.103

F.

Sharing Lessons Learned

In the broader context of health system policy, emerging countries’
public health and health care systems offer both positive and negative
lessons about health development. Such lessons can stand as role models
or warnings for health policy-making in the developing world. The positive
98. Longde Wang et al., Emergence and Control of Infectious Diseases in China, 372
LANCET 1598, 1603 (2008).
99. Id.
100. Changhong Yang et al., Use of Mobile Phones in an Emergency Reporting System for
Infectious Disease Surveillance After the Sichuan Earthquake in China, 87 BULL. WORLD
HEALTH ORG. 619, 619 (2009).
101. World Health Organization, Developing Countries’ Vaccine Regulators Network
Establishment,
http://www.who.int/immunization_standards/vaccine_regulation/dcvrn/en/
(last visited Sep. 3, 2010).
102. Id.
103. Id.
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role models underline the importance of an egalitarian ethos and
government attention to health and social spending. Brazil, for example,
has achieved successes in both its public health programs and health system
development. At a foundational level, a strong and clear commitment to
universality and equality motivates Brazil’s health system. This commitment
is visible in numerous system components. In its 1988 National Constitution,
for instance, Brazil established health care as a “right of all and the duty of
the state.”104 The Unified Health System was created, under which
government health priorities, planning programs, and resource allocation
are decided with the participation of state and local health councils and
consumer representation.105 Civil society health advocacy groups, including
those working with sex workers and intravenous drug users, receive
government funding.106 In the early 1990s, as part of a set of health policy
reforms, the Brazilian government developed the Family Health Program
(“FHP”), designed to reach out and serve poor families in rural areas; by
2009, the program has expanded to reach nearly fifty percent of the
population.107 As early as the 1940s, the Brazilian government, with United
States assistance, had set up another outreach program targeting the
populations of the Amazon.108 This program, eventually absorbed into the
Brazilian Ministry of Health, sought to address a wide range of health issues,
from water and sanitation systems to the control of infectious diseases like
malaria and Chagas.109 A recent discussion of this program suggests it has
“many lessons for the planners of health and disease control projects in
tropical, low-income countries.”110 Brazil’s powerful egalitarian ethos has
shaped these initiatives.
The Indian state of Kerala has long been viewed as not only exemplary,
but a model for “the rest of India and third world countries in providing
primary health care.”111 Even though Kerala is quite poor economically,
with a per capita income of one percent of the highest-income countries,
Kerala has achieved low infant mortality rates and high life expectancy with

104. Okie, supra note 48, at 1979. See also Kenneth Rochel de Camargo, Celebrating
the 20th Anniversary of Ulysses Guimarães’ Rebirth of Brazilian Democracy and the Creation
of Brazil’s National Health Care System, 99 AM. J. PUB. HEALTH 30, 31 (2009).
105. Id. at 1979-80.
106. Id. at 1980.
107. Mauricio L. Barreto & Rosana Aquino, Recent Positive Developments in the Brazilian
Health System, 99 AM. J. PUB. HEALTH 8, 8 (2009).
108. Amelia L. Mayberry & Timothy D. Baker, Letter to Editor, Lessons from a Special
Service for Public Health, Brazil, 15 EMERG.INFECT. DISEASES 1693, 1693 (2009).
109. Id.
110. Id.
111. C.R. Sonam, Kerala’s Crisis in Public Health, BOLOJI.COM, Feb. 3, 2007,
http://www.boloji.com/analysis2/0182.htm (last visited Sep. 3, 2010).
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very modest investments in health care.112 As in Brazil, an egalitarian ethos
permeates the system in Kerala, which boasts a “relatively fair distribution of
wealth and resources across nearly the entire population of the state,”113 as
well as high female literacy and a strong political commitment to social
spending.114 Kerala also has a potpourri of other social investments,
including, for example, a public distribution system for subsidized essential
foods, land reforms that benefit the poor and landless, and a strong
These, too, are
transportation and communication infrastructure.115
programs to emulate.
Other currently and formerly emerging countries provide models and
pointers for health policy reforms. Morocco, Mexico, and South Korea are
examples of countries undertaking the expansion of health insurance
coverage, or, in the case of South Korea, actually attaining universal
insurance. In 2005, Morocco approved two reforms, one to expand
coverage of the payroll-based mandatory insurance for public and formal
private-sector employees, and the other to cover services for the poor
through a public fund.116 Despite the competing concerns of various
stakeholders (e.g., medical professionals worried about compensation and
insurers uncertain about the effects of reform), in Morocco they have
reached “substantial agreement around the need for greater solidarity and
equity in access” to quality care, and also for more resources and
government oversight.117 This was achieved over a fifteen-year debate
involving politicians, health care providers, employers, trade unions,
insurers, national social security funds, international organizations and
donors, NGOs, and the public, showing the importance of broad
consultation with and participation by affected parties.118
The Mexican reform launched in 2003 aims to redress the segmentation
of its health system. The new Popular Health Insurance scheme (“PHI”)
supplements the two older insurance schemes that cover private-sector
workers, government workers, and their families; it offers subsidized, publicly

112. K.R. Thankappan, Some Health Implications of Globalization in Kerala, India, 79
BULL. WORLD HEALTH ORG. 892, 892 (2001).
113. Id.
114. Id. (accounting for about forty percent of the total expenditure). See also
InfoChangeIndia.org, State Wise Social Sector Spending as Percentage of Total Expenditure,
http://infochangeindia.org/200210025816/Governance/Statistics/State-wise-social-sectorspending-as-percentage-of-total-expenditure.html (last visited Sep. 3, 2010) (describing the
growing percentage of social sector spending between 2001 and 2004).
115. Thankappan, supra note 112, at 892.
116. Jennifer Prah Ruger & Daniel Kress, Health Financing and Insurance Reform in
Morocco, 26 HEALTH AFF. 1009, 1009 (2007).
117. Id. at 1011.
118. Id.
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provided health insurance to the fifty million who were left behind by those
programs.119 Attainment of universal coverage is projected for 2011.120
One emphasis of this reform is solidarity. The federal government’s fixed
contribution for each family is equal across all three insurance schemes,
which promotes solidarity among the population, regardless of work
status.121 Another funding component involves the federal government and
“co-responsible contributor[s],” which are state governments for PHI.122
Here, federal contribution is not fixed, but is “increased for poorer states at
the expense of those that are wealthier.”123 This promotion of universal
protection and fair financing echoes the egalitarianism underlying the public
health successes of Brazil and Kerala.
South Korea, now a fully developed country, exemplifies one route to
universal national health insurance. Like China, South Korea developed
quite rapidly. In the span of twelve years, 1977-1989, it achieved universal
health insurance through government-mandated coverage expansions that
first targeted large firms with more than 500 employees, then the public
sectors and smaller firms, and finally, remaining rural and urban
residents.124 Up until 1996, South Korea had been able to fund its national
health insurance without deficits.125 The 1997 Asian financial crisis
contributed to funding problems, but the main causes have been traced to
the government’s shortcomings in regulating the supply of costlier medical
specialists relative to the supply of generalists, controlling excessive use of
expensive technologies by private hospitals and facilities, limiting out-ofpocket expenditures, reforming its pharmaceutical industry and regulatory
framework, and countering the multinational pharmaceutical companies’
promotional campaigns for expensive drugs.126 But despite these difficulties
in supply-side market regulation, South Korea demonstrates that universal

119. Felicia Marie Knaul & Julio Frenk, Health Insurance in Mexico: Achieving Universal
Coverage Through Structural Reform, 24 HEALTH AFF. 1467, 1468, 1470 (2005).
120. Suzanne Stephens Waller, Mexico to Achieve Universal Health Coverage by 2011:
President Calderón, PRESIDENCIA DE LA REPUBLICA, Feb. 16, 2009, http://presidencia.gob.mx/
en/press/?contenido=42321.
121. Knaul & Frenk, supra note 119, at 1470.
122. Id.
123. Id. at 1471.
124. Jong-Chan Lee, Health Care Reform in South Korea: Success or Failure?, 93 AM. J.
PUB. HEALTH 48, 48 (2003).
125. Id. at 50.
126. Id.; see also Jennifer Prah Ruger & Hak-Ju Kim, Out-of-Pocket Healthcare Spending
by the Poor and Chronically Ill in the Republic of Korea, 97 AM. J. PUB. HEALTH 804 (2007);
Hak-Ju Kim & Jennifer Prah Ruger, Pharmaceutical Reform in South Korea and the Lessons It
Provides, 27 HEALTH AFF. W260 (2008).
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health coverage can be achieved alongside economic development, and
within a relatively brief time.
In contrast to these role models, the experiences of China, Russia, and
India (beyond Kerala) are object lessons that admonish against insufficiently
regulated and excessive privatization and decentralization, and reveal the
continuing importance of state stewardship of national health systems.
India’s public health system “stagnated even as incomes have
grown.”127 Decline in government spending and limited health insurance
coverage are major contributors to poor performance.128 The pressure to
increase economic growth and India’s IMF-mandated structural adjustment
in the 1990s led to regressive policies such as the reduction of resources for
health and social sectors.129 User fees were imposed for public health
facilities.130 Only about fifteen percent of the Indian population has health
Out-of-pocket (“OOP”) payments as a
insurance of any kind.131
percentage of income in India exceeded ten percent for all residents except
the richest urban quintile in 2004, and less well-off households risk sinking
below the poverty line because of OOP payments.132 Health spending as a
percentage of gross domestic product (“GDP”) increased from three and a
half to five percent between 1988 and 2000, but this increase partly reflects
Inadequately regulated privatization has
“waste and inefficiency.”133
spurred overprescription of drugs and tests and unnecessary use of
technology in richer locales, while public budget cuts have contributed to
drug shortage and worker absenteeism in less prosperous areas.134 Even
Kerala, India’s success story, is not immune. Household health expenditures
in Kerala went up about 517% between 1987 and 1996, driven by
increasing privatization and rising drug prices.135 Additionally, many
Keralite health professionals leave the public sector, especially in rural

127. Prologue: China and India: Reform Goes Global, 27 HEALTH AFF. 920, 920 (2008).
128. Winnie Yip & Ajay Mahal, The Health Care Systems of China and India: Performance
and Future Challenges, 27 HEALTH AFF. 921, 926 (2008). See also Thankappan, supra note
112, at 892.
129. SANDHYA SRINIVASAN & MINI SUKUMAR, LIBERALIZATION AND HIV IN KERALA, 3-4, 7 (United
Nations Research Inst. for Social Dev. 2006), available at http://www.unrisd.org/80256B3C0
05BCCF9/%28httpAuxPages%29/5F04F53D5B1D9F13C1257177004919B3/$file/Srinivasa
n-pp.pdf
130. Id. at 7, 8.
131. Yip & Mahal, supra note 128, at 927.
132. Id. at 922-23.
133. Id. at 924.
134. Id. at 925-26.
135. Thankappan, supra note 112, at 892.
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primary care clinics, because they are drawn to more lucrative private sector
work,136 thus further eroding the strength of Kerala’s public health system.
In China, economic reforms since 1978 “destroy[ed] the nation’s public
health system,” leaving “much of the population” uninsured and
unprotected from health-related financial risks.137 Before 1979, China
provided “near-universal” coverage through the Cooperative Medical
Scheme (“CMS”) in rural areas, and the Government Insurance Scheme
(“GIS”) and Labor Insurance Scheme (“LIS”) in urban areas.138 Reform of
the rural economy in 1979 established the Household Responsibility System,
which replaced the communes that financed CMS.139 Ninety percent of
peasants were left uninsured by the disintegration of that insurance
scheme.140 GIS and LIS were replaced by a city-based social health
insurance scheme that only covered formal-sector workers and excluded
their dependents, migrants, and informal-sector workers.141 Changing from
a centrally planned economy to one based on market competition shrank
the Chinese state sector and lowered government revenue.142 Health
spending came to be seen as a low-priority budget item, and government
spending as a proportion of health spending decreased from approximately
thirty percent to around fifteen percent.143 By the early 1990s, government
subsidies as a portion of public health facilities revenue fell to just ten
percent.144 In a bid to keep services affordable, the government set belowcost prices for basic health care, but it set high prices for drugs and hightech diagnostic services to keep facilities solvent.145 These moves created
problematic incentives; when public health facilities had to realize ninety
percent of their revenues from moneymaking activities, they became profit
seekers.146 Service provision is down, and costs are up. In rural areas, the
lowest income quintile spends about twenty-seven percent of its income on
OOP payments; in 2003, almost fifty percent of those reporting illness had
forgone outpatient care, and almost forty percent of that group cited
finances as the reason.147 In response to these access problems, China in
2009 launched a health initiative to achieve insurance coverage of essential

136.
137.
138.
139.
140.
141.
142.
143.
144.
145.
146.
147.

Sonam, supra note 111.

Prologue: China and India: Reform Goes Global, supra note 127.
Yip & Mahal, supra note 128, at 927.
Id.
Id.
Id.
Id. at 926.
Id.
Id. at 928.
Id.
Id.
Id. at 922-23.

SAINT LOUIS UNIVERSITY SCHOOL OF LAW

272

SAINT LOUIS UNIVERSITY JOURNAL OF HEALTH LAW & POLICY

[Vol. 3:253

health services for ninety percent of the population by the end of 2010, with
the goal of universal coverage by 2020.148 To this end, the government has
so far committed $125 billion over three years.149
Russia is probably the most vivid example of a wholesale public health
system collapse. Since the demise of the Soviet Union, Russia has taken
what some call the “Great Leap Downward,”150 whereby reversals in health
achievements have been the norm rather than the exception, especially with
regard to cardiovascular diseases and drug- and alcohol-related injuries
and poisoning.151 Moreover, between 1990 and 1994, there was a fiftyfold increase in diphtheria, and a doubling in TB prevalence between 1991
and 1998.152 Russia’s government spending on the health care system has
severely contracted—in a mere three years, it dropped from 6.2% of GDP in
2002 to three percent just prior to 2006.153 Goods and services have been
decentralized, leading to reduced access and quality, higher costs, and a
weakening of the overall infrastructure.154 The system falls short of meeting
the health needs of people living with HIV and AIDS. Russia has around
seventy percent of all HIV cases in Eastern Europe and Central Asia, with
one of the world’s fastest growing HIV epidemics, yet only six to fifteen
percent of those in need have access to antiretroviral treatment (“ART”).155
In a lesson of what to avoid in health systems management, the Soviet
Ministry of Health built a “separate centralized network of AIDS centers,” not
integrated into the broader health care system.156 Observers in 2006
remarked that, “to this day,” providers in the AIDS centers “generally
remained poorly trained and informed about the disease.”157 Abstinencebased programs and deficits in addressing transmission among intravenous
drug users have also contributed to failures in HIV/AIDS care, as in other

148. Yan Guo et al., Tracking China’s Health Reform, 375 LANCET 1056, 1056 (2010).
149. Id.
150. Nicholas Eberstadt & Apoorva Shah, Russia’s Great Leap Downward, J. INT’L SEC.
AFF., Fall 2009, at 73, 73.
151. Id. at 79-80.
152. Col Alan R. Constantian, Russia’s Public Health: National Security Issue for the United
States? 170 MILITARY MED. 285, 285 (2005).
153. Tracey Lynn Koehlmoos, Adjunct Professor, George Mason Univ., Lecture: The
Russian Healthcare System, http://gunston.gmu.edu/healthscience/InternationalHealth/The
RussianHealthcareSystem.ppt (last visited Sep. 3, 2010) (detailing the organization and
operation of the Russian healthcare system).
154. Id.
155. MORRISON & KATES, supra note 4, at 10, 13.
156. Id. at 11.
157. Id.
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parts of the world.158 One bright spot in Russia’s AIDS picture, with positive
lessons for other countries, is its exemplary program to prevent mother-tochild transmission.159
Incentives are important for the design and performance of health
programs, and inadequate consideration for economic realities can
generate perverse incentives and outcomes. South Africa’s Disability Grant
is a case in point.160 This grant is meant to ensure that HIV/AIDS patients
can afford adequate nutrition and transportation to clinics.161 Eligibility is
“temporary and contingent” on the recipient’s CD4 count.162 The Disability
Grant is the “only form of social security available to working-age adults in
This proves unfortunate in a country with an
South Africa.”163
unemployment rate that hovers around forty percent; since jobs are so
scarce, the Disability Grant is frequently used to support whole families,
rather than merely to supplement HIV/AIDS treatment.164 Patients are
believed to default on treatment in order to keep the grant, although more
recent empirical research has called this into question.165 Fearing fraud, the
South African government has strengthened enforcement during the annual
grant review, causing many patients to lose the grant after commencing
ART.166 Chinese pricing of health services, as described earlier, also creates
counterproductive incentives that undermine medical professional ethics and
norms.167 Seeing the need for incentive reform, the Chinese government
has encouraged cities and localities to experiment with various schemes,
many of which involve switching from retrospective fee-for-service payment
to aggregated and prospective payment methods with performance-linked
incentives.168

158. Associated Press, Russia Is Urged to Switch Its Approach to Curbing Spread of H.I.V.,
N.Y. TIMES, Oct. 29, 2009, at A7 (describing Russia’s adherence to abstinence-only program

on HIV prevention).
159. Id.
160. See generally PlusNews, South Africa: Disability Grant Cutoff Threatens Livelihoods of
People on Treatment, PLUSNEWS.ORG, Sep. 2006, http://www.plusnews.org/InDepthMain.
aspx?InDepthId=40&ReportId=70992 (last visited Sep. 3, 2010) (detailing the impact of
South Africa’s disability grant for HIV patients); see also Atheendar Venkataramani et al.,

Social Grants, Welfare, and the Incentive to Trade-Off Health for Income Among Individuals
on HAART in South Africa, AIDS & BEHAV. (2009) (published online).
161. PlusNews, supra note 160.
162. Id.
163. Id.
164. Id.
165. Venkataramani et al., supra note 160.
166. PlusNews, supra note 160.
167. Winnie Chi-Man Yip et al., Realignment of Incentives for Health-Care Providers in
China, 375 LANCET 1120, 1120 (2010).
168. Id. at 1121.
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The cautionary examples of India, China, Russia, and South Africa show
that health systems cannot be developed or maintained in isolation from
other social and economic challenges and government policies. They are
arguments for a comprehensive, multi-sector approach to health system
development and health policy-making.

G. Expanding Economies and Reducing Poverty
As discussed above, emerging countries like BRIC are in position to
provide other developing countries with financial, material, and technical
assistance, and to model both positive and negative lessons in public health
and health care development. With their burgeoning economies and rising
regional and international clout, BRIC also have the ability to help
developing countries address the economic determinants of health, by
assisting with the expansion of their economies and the reduction of poverty,
which is associated with poor health. A growing economy provides the
necessary resources for health system development, both initial investments
and recurring expenditures.
Regional trade agreements (“RTA”) are one way to open markets to
developing countries. These preferential trade agreements reduce tariffs
and restrictions on trade among members; some may also apply a common
external tariff toward non-members, or perhaps engage in even deeper
economic integration, such as common currencies.169 The BRIC countries
are involved in a number of RTAs. Brazil is part of Mercosur, the full and
associate members of which include Argentina, Paraguay, Uruguay,
Venezuela, Bolivia, Chile, Colombia, Ecuador, and Peru.170 Mercosur is a
free trade zone and a customs union, with aims toward a common
currency.171 Russia has been a member of the Eurasian Economic
Community (“EAEC”) since 2000, along with Belarus, Kazakhstan,
Kyrgyzstan and Tajikistan; Armenia, Moldova, and the Ukraine are
observers.172 The goals of EAEC include the free trade of goods,
encouragement of investments, a common market for energy, and a
common system for customs regulation.173 To deepen the EAEC economic
169. Ildikó Virág-Neumann, Regional Trade Agreements and the WTO, in 7th
INTERNATIONAL CONFERENCE ON MANAGEMENT, ENTERPRISE AND BENCHMARKING 381, 382-84
(2009) (explaining the relationship between RTAs and the WTO).
170. Joanna Klonsky & Stephanie Hanson, Mercosur: South America’s Fractious Trade
Bloc, COUNCIL ON FOREIGN RELATIONS, http://www.cfr.org/publication/12762 (last visited
Sep. 3, 2010).
171. Id.
172. Eurasian Home Analytical Resource, Eurasian Economic Community (EAEC),
http://eurasianhome.org/xml/t/databases.xml?lang=en&nic=databases&intorg=3&pid=25
(last visited Sep. 7, 2010).
173. Id.
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integration process, Russia announced plans to establish a Common
Economic Space with Belarus and Kazakhstan, which entails a customs
union effective this year.174 China and India both have free trade
agreements with the Association of Southeast Asian Nations (“ASEAN”)
starting this year, opening up their markets to the Southeast Asian countries
of Brunei, Myanmar, Cambodia, Indonesia, Laos, Malaysia, Philippines,
Singapore, Thailand, and Vietnam.175 India also has a preferential trade
agreement with Mercosur.176 These are prominent examples of RTAs.
Because of lower tariffs, regional trade partners benefit from cheaper
goods for consumers. For instance, average tariff rates on both Chinese
goods sold in ASEAN countries and ASEAN goods sold in China has
decreased to near zero.177 Trading partners additionally gain access to new
markets for export, which profits domestic businesses. However, RTAs are
not simple instruments; though they liberalize trade among member states,
RTAs may have negative consequences such as encouraging costlier imports
from member countries at the expense of less expensive goods from nonmembers, which could potentially harm consumers in these developing
countries.178 There are also concerns that industries and sectors in the
smaller trading partners’ economies may not be able to withstand
competition from the BRIC economies, especially China.179

174. Xinhua News Agency, Russia, Belarus, Kazakhstan to Establish Common Economic
Space Before 2012, CHINA VIEW, Dec. 20, 2009, http://news.xinhuanet.com/english/200912/20/content_12672863.htm (last visited Sep. 7, 2010).
175. John Wong & Sarah Chan, China-ASEAN Free Trade Agreement: Shaping Future
Economic Relations, 43 ASIAN SURVEY 507, 508, 508 n.3 (2003) (explaining the potential for a
free trade agreement to open up trade between China and East Asia); TULI SINHA, INST. OF
PEACE AND CONFLICT STUDIES SPECIAL REPORT: INDIA-ASEAN FREE TRADE AGREEMENT: A SURVEY OF
LITERATURE 4 (2009); India-ASEAN Free Trade Agreement to Come into Force in January
2010, SIFY.COM, Nov. 23, 2009, http://sify.com/finance/india-asean-free-trade-agreementto-come-into-force-in-january-2010-news-news-jlxsudjajdj.html
176. Preferential Trade Agreement Between Mercosur and the Republic of India, Jan. 25,
2004, available at http://www.commerce.nic.in/trade/indiamercosur/pta_indiaandmercosu
r.pdf.
177. Stephen Coates, ASEAN-China Open Free Trade Area, SYDNEY MORNING HERALD,
Dec. 30, 2009, available at http://news.smh.com.au/breaking-news-world/aseanchina-openfree-trade-area-20091230-ljht.html (noting that the average tariff rate for goods imported
into China from ASEAN countries would drop from 9.8% to 0.1%, and that the tariff rates for
goods exported from China to ASEAN countries would drop from 12.8% from 0.6%).
178. Alexander J. Yeats, Does Mercosur’s Trade Performance Raise Concerns About the
Effects of Regional Trade Arrangements?, 12 WORLD BANK ECON. REV. 1, 2, 26 (1998)
(explaining that discriminatory trade barriers could deny access to higher-quality lower-priced
goods for consumers in Mercosur).
179. The China-ASEAN Free Trade Agreement: Ajar for Business, ECONOMIST Jan. 9,
2010, at 44, 44.
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Yet RTAs can also be designed to ensure aid to development. South
Africa anchors a free trade arrangement that has an explicit development
component, the Southern African Customs Union (“SACU”).180 This customs
union provides for free trade among South Africa, Botswana, Lesotho,
Namibia, and Swaziland, and erects a common external tariff and a
common excise tariff for the group.181 South Africa acts as the custodian of
the Revenue Fund, into which all common customs revenue is paid.182
Revenue is distributed to Botswana, Lesotho, Namibia, and Swaziland in
accordance with a revenue-sharing formula, with South Africa retaining the
residuals.183 A portion of SACU revenue derived from the excise tariff is
earmarked for development.184 This portion is calculated for member
countries based on the inverse of each country’s per capita GDP,185 thus
serving a redistributive function.
Economic assistance comes in other forms as well. China, for example,
announced an aid package for ASEAN worth billions of dollars to further
China-ASEAN cooperation.186 The aid includes investments in infrastructure
construction, energy, information, and communications; preferential loans;
scholarships; and rice for the emergency East Asia rice reserve.187 In 2007,
China set aside for Africa about five billion dollars in investments and
another five billion dollars in loans and credits, with no political strings
attached.188 In 2005, Russia, as a member of the G8, participated in
forgiving at least forty billion dollars in debt for eighteen of the world’s
poorest countries.189 Debt relief and development assistance can redirect

180. Southern African Customs Union, About SACU, http://www.sacu.int/about.php?
include=about/history.html (last visited Sep. 7, 2010) (explaining the history and present
status of the Southern African Customs Union).
181. Id.
182. Department of International Relations and Cooperation of South Africa, Southern
African Customs Union (SACU): History and Present Status (2004), available at
http://www.dfa.gov.za/foreign/Multilateral/africa/sacu.htm (accessed Sep. 7, 2010).
183. Id.
184. Id.; see also Southern African Customs Union, 2002 Southern African Customs Union
(SACU) Agreement, Part 7, art. 34: Revenue Sharing Formula, http://www.sacu.int/main.php?
include=docs/legislation/2002-agreement/part7.html (last visited Sep. 7, 2010).
185. Id.
186. Xinhua News Agency, China Rolls Out Assistance Blueprint for ASEAN, CHINA VIEW,
Apr. 12, 2009, http://news.xinhuanet.com/english/2009-04/12/content_11173381.htm.
187. Id.
188. Chinese Aid Flows into Africa, supra note 12.
189. RONALD LABONTE ET AL., FATAL INDIFFERENCE: THE G8, AFRICA AND GLOBAL HEALTH xiv
(2004) (explaining how Russia’s membership in the group known as the G7 created the G8);
G8 Agree to Cancel $40B in Debt Owed by 18 of World’s Poorest Countries, MEDICAL NEWS
TODAY, June 14, 2005, http://www.medicalnewstoday.com/articles/26090.php (last visited
Sep. 7, 2010).
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national spending away from debt service and toward health and social
spending. As such, they can be a “vital element” in meeting the Millennium
Development Goals for health.190
Economic assistance does not have to be monetary. Brazil, for instance,
strengthened the ability of developing countries to participate effectively in
WTO agricultural negotiations by leading the organization and coordination
of G20.191 G20 members have disparate, even conflicting positions in
agricultural negotiations, but Brazil’s technical experts from government and
the private sector played a large part in generating technically consistent
proposals that brought G20 recognition as a major new actor in agricultural
negotiations.192 To the extent that such efforts improve the trading positions
of developing countries, they confer economic advantages.

H. Taking a Role in Global Health Governance
Emerging countries have a role in global health governance. A
multiplicity of actors and agendas characterizes the current global health
architecture. The actors include (but are not limited to) the World Bank,
WHO, UNAIDS, UNICEF, NGOs, think tanks, The Global Fund, entities
such as the Gates, Ford and Rockefeller foundations, the EU, the USA, other
developed countries, and now emerging countries.193 The growth of
emerging countries as major new international players with political and
financial clout to influence global and domestic health agendas adds to the
global health architecture’s pluralism and fragmentation, possibly
exacerbating the lack of coordination and the often ad hoc nature of the
global health agenda.194 Emerging countries’ activities would have greater
chances of success if players took effective steps to avoid duplication and
inadvertent conflict with the efforts of other global health actors and
funders.195 This need creates an even more compelling rationale for an
overarching institution to set the global agenda and coordinate policy.196

190. G8 Agree to Cancel $40B in Debt Owed by 18 of World’s Poorest Countries, supra
note 189.
191. Pedro da Motta Veiga, Brazil and the G-20 Group of Developing Countries, in
MANAGING THE CHALLENGES OF WTO PARTICIPATION: 45 CASE STUDIES 109 (Peter Gallagher et
al. eds., 2005), available at http://www.wto.org/english/res_e/booksp_e/casestudies_e/case
7_e.htm (arguing that Brazil helped form the G-20 to help developing countries bargain
jointly).
192. Id. at 115.
193. Jennifer Prah Ruger & Derek Yach, Global Functions at the World Health
Organization, 330 BRIT. MED. J. 1099, 1100 (2005) (discussing the growth of pluralism in
international health).
194. Id.
195. See generally id.
196. See generally id.
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The WHO is one possibility in this regard.197 The general wish of the global
health community for more coordination might be seen in the election of
Margaret Chan as WHO Director-General in 2006, which was described by
some as reflective of “[i]nternational desire for more cooperation from
China.”198
There is another story to be told about emerging countries’ role,
however—about their potential as counterbalance or counterforce to more
“powerful” countries. Brazil, Russia, India, and China publicly declared
themselves a cooperative group with the first BRIC summit.199 There, BRIC
issued joint statements that, among other things, called for greater
representation of emerging and developing economies in international
financial institutions, and comprehensive reform of the United Nations to
include greater status for India and Brazil.200 This BRIC summit followed
directly on the heels of a meeting of the Shanghai Cooperation
Organization (“SCO”), a regional forum for security and economic
cooperation of Central Asian states, led by Russia and China.201 The desire
to counterbalance the established powers is clear in “a common thread” at
the SCO and BRIC summits, the “discussion of a new world order less
dependent on the United States.”202
The BRIC countries act in other combinations as well. Brazil, India, and
South Africa, for example, formed a “trilateral alliance” in 2003 called the
India, Brazil, and South Africa Dialogue Forum (“IBSA”) to coordinate and
“maximize joint actions” in pursuit of mutual interests within international
organizations like the WTO.203 The intent was to “hold regular political
consultations”, share information, and coordinate positions.204 Some of the
issues addressed by IBSA include pharmaceutical patents, public health, and
government subsidies.205 IBSA as a bloc has also sought alliances with
other countries such as China and Argentina around specific global issues

197. Id. (describing WHO’s current operational framework).
198. Gretchen Vogel, SARS and Bird Flu Veteran to Take WHO Helm, 314 SCIENCE 1067,
1067 (2006) (“The vote . . . was as much a vote for China as it was for Margaret Chan.”)
(internal quotations omitted).
199. Dmitry Medvedev, President of Russia, Opening Address at Restricted Format Meeting
of BRIC Leaders (June 16, 2009), http://archive.kremlin.ru/eng/text/speeches/2009/06/16/
2230_type82914_217934.shtml.
200. President of Russia Official Web Portal, Joint Statement of the BRIC Countries’
Leaders (June 16, 2009), http://archive.kremlin.ru/eng/text/docs/2009/06/217963.shtml.
201. Faulconbridge, supra note 13.
202. Id.
203. Gladys Lechini, Middle Powers: IBSA and the New South-South Cooperation, NACLA
REP. ON AM., Sep.-Oct. 2007, at 28, 28.
204. Id. at 29.
205. Id. at 28.
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like agricultural policy and subsidies.206 Thus, IBSA, and those with which it
coordinates, aim to use their collective clout to win concessions on issues of
special relevance.207 This “soft balancing” technique combines economic,
diplomatic, and institutional tools to challenge the position of major
powers.208 It may be a harbinger of negotiations to come as emerging
countries both develop and cooperate more effectively.
Some BRIC countries have transitioned to more “elite” status in global
governance and thus assume greater political weight. Russia, for example,
is a member of G8,209 and even though the G8 is more of a supplemental
global health governance model with a decidedly top-down aspect, it is
nonetheless influential. As G8 president in 2006, Russia committed to
increasing the importance and visibility of HIV/AIDS as a central theme of
G8 action, despite its own HIV/AIDS failures, and emphasized the need to
meet existing pledges and commitments as opposed to starting completely
new endeavors.210 Russia also reached out to the other BRIC countries,
South Africa, and Mexico to participate in an April 2006 health ministerial
session in Moscow.211 Regionally, Russia was active in coordinating a
Commonwealth of Independent States (“CIS”) Inter-Parliamentary Assembly
working group in 2002 that drafted a model law, “On Prevention of
Spreading of HIV/AIDS in CIS Countries,” and hosted a 2005 ministerial
meeting, “Urgent Response to HIV/AIDS Epidemics in the Commonwealth of
Independent States,” in Moscow.”212 From that meeting came the Moscow
Declaration emphasizing the need to scale up HIV responses in CIS.213
Moscow then hosted, in 2006, the first regional Eastern European and
Central Asia AIDS conference.214

I.

Linking Health and Foreign Policy

Health issues are becoming an important focus in foreign policy.
Global interdependence with its massive volumes of international trade and
travel means that health hazards anywhere in the world can potentially
threaten citizens of every country. Border-crossing infectious diseases (like
SARS and influenza) and the specter of bioterrorism place health within the
national security realm. HIV/AIDS poses serious risks to international and

206.
207.
208.
209.
210.
211.
212.
213.
214.

Id. at 29.
Id.
Id. at 31.
MORRISON & KATES, supra note 4, at 1.
Id. at 6.

Id.
Id. at 12.
Id.
Id.
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regional stability by disrupting the demographic, social, economic, and
political structures of states. Economic interests are at issue, too, since
healthy populations—which are more productive and likely to have more
disposable income—are better workers and consumers who contribute more
to economic growth.215 For countries confronting overwhelming health
challenges, such as those in sub-Saharan Africa, foreign policies concerning
access to drugs and resources for health programs may be, without much
exaggeration, a matter of national survival.
The signs of health’s
ascendance in foreign policy are clear. The United Nations Security Council
debated HIV/AIDS for the first time in 2000, the same year the leading
world economies comprising the G8 committed to the establishment of the
Global Fund.216
The treatment of health as a national economic and security interest
elevates health’s status in international relations, and along with that come
more attention and resources. Health becomes an investment in economic
productivity, harm prevention, and future cost savings.217 This “investmentbased global-health debate” basically makes the argument of “increased
interdependence, threat to the rich countries if they do not act, and great
economic benefits for all if they do.”218 It is a simple, compelling appeal to
enlightened self-interest. This argument has important policy implications,
specifically that “the global disease burden must be explained by a lack of
good governance, of money, and of efficiency in implementation,” and not
by “inherently political decisions and the distribution of power.”219 This
obscures the real effects of the fundamental international disparity in
economic and political power. For example, developing countries’ tropical
diseases are ignored in pharmaceutical research and development—which
takes place largely in advanced industrialized countries—because poor
countries do not have the economic power to render such ventures
profitable.220 Out of the 1,223 new chemical entities brought to market

215. Editorial, The Self-Interest Case for US Global Health Cooperation, 349 LANCET
1037, 1037 (1997) (arguing that economic “greed” is a reason for the Institute of Medicine’s
Board on International Health to expand American efforts to improve global health).
216. S.C. Res. 1308, U.N. Doc. S/RES/1308 (July 17, 2000), available at
http://www.securitycouncilreport.org/atf/cf/%7B65BFCF9B-6D27-4E9C-8CD3-CF6E4FF96F
F9%7D/CC%20SRES%201308.pdf (adopting resolution to address the HIV/AIDS pandemic);
MORRISON & KATES, supra note 4, at 5 (Global Fund arose out of the 2000 G-8 summit in
Okinawa, Japan.).
217. Ilona Kickbusch, Influence and Opportunity: Reflections on the U.S. Role in Global
Public Health, 21 HEALTH AFF. 131, 134, 135 (2002).
218. Id. at 135.
219. Id.
220. Bernard Pécoul et al., Access to Essential Drugs in Poor Countries: A Lost Battle?,
281 JAMA 361, 363 (1999) (e.g., chloramphenicol is a simple and low cost treatment for
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between 1975 and 1997, only one percent are for tropical diseases, and
only 0.3% were direct products of pharmaceutical—as opposed to military
or veterinary—research and development.221 A low-income country with
good governance and efficient policy implementation would still have
trouble with disease burdens if the necessary drugs do not exist.
The national interest approach to health exists in tension with an
approach that calls for a global and provincial consensus on the morality of
health.222 National interest does not necessarily value health for its own
sake. It does not take the view that health is a special social good, which
every country has a responsibility to promote, particularly among its own
citizens but also among citizens of the world. Rather, health as a national
interest is handled politically, not medically, nor always in an evidencebased manner. G8 countries, which established the Global Fund for AIDS,
Malaria, and Tuberculosis, take little action on tobacco, a major cause of
chronic illness and a public health threat.223 Health got onto the foreign
policy agenda, but it is still a relatively low priority.224 When health comes
into conflict with powerful economic interests—such as the pharmaceutical
industry—it is likely to end up on the losing side.
Why is a discussion of health and foreign policy important for BRIC? To
a global health approach that privileges health as a special social good,
distinct and separate from other social goods like economic growth and
trade, BRIC can contribute many useful lessons. Their experiences and
ongoing challenges show that health does not need to be—and should not
be—sacrificed or traded off in the pursuit of economic growth. An inclusive
approach that sets priorities and allocates resources in consultation with
affected parties and which gives extra help to the most disadvantaged
should be taken.225 Some of the emerging countries already practice this
type of health governance at the national or local level. The egalitarianism
of the Brazilian, Keralan, and Mexican public health systems, the strong civic

bacterial meningitis, of which there were over 100,000 cases in Nigeria in 1996, but the drug
was not available in sufficient quantities).
221. Id. at 364 (citing P. Trouiller et al., Analysis of Drug Development Patterns of Six
Tropical Diseases Between 1975 and 1997 (1998) (unpublished manuscript presented at the
Eighth International Congress on Infectious Diseases, May 15-18, Boston, Mass.)).
222. See generally Jennifer Prah Ruger, Global Health Justice, 2 PUB. HEALTH ETHICS 261,
261 (2009) (arguing for a view of “global health justice” that relies on “provincial globalism,”
a global and provincial consensus).
223. LABONTE ET AL., supra note 189, at 42, 71.
224. Id. at 73-75 (describing shortcomings of G8 efforts with respect to health goals).
225. See generally Jennifer Prah Ruger, Ethics and Governance of Global Health
Inequalities, 60 J. EPIDEMIOLOGY & COMMUNITY HEALTH 998 (2006) (discussing the moral
basis for public health activities, who has the responsibility to act, what they should do, and
how they might do it).
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engagement of the highly lauded Brazilian HIV/AIDS program, and the
deliberative process and consensus achieved in Moroccan health reform are
a few examples of this type of health governance at work.226
As emerging countries gain a more powerful voice in international
affairs, they can draw attention to their successes and help take “shared
health governance” to the global level through leading by example. With
growing economic and political strength, these countries can make more
forceful demands for the collective agency of the developing world, so that
the needs and interests of recipient states can be properly considered and
accounted for in global and international health action. And these countries
can increase their individual and collective clout in international
organizations and advocate for the need to coordinate policies across
sectors—such as trade and health—to improve health outcomes.
As we have seen, BRIC are now featured prominently in political
relationships at the regional and global level and in international diplomatic
relations. Emerging countries like the BRIC nations are becoming economic
and political forces to be reckoned with, but they also bring the concerns
and claims of the developing world to the foreign policy table. In the arena
of essential drugs, for instance, they have already made notable progress in
shifting norms toward a duty to access.
To promote the integration of health issues in foreign policy, several
emerging countries have participated in the launch of the Foreign Policy and
Global Health Initiative (“FPGH”).227 Participants are Brazil, France,
Indonesia, Norway, Senegal, South Africa, and Thailand.228 This is a step
toward “a more sustainable relationship between foreign policy and
health.”229
III. SOME NECESSARY CAVEATS

A. Emerging and Transitioning
Emerging and transitioning countries—especially BRIC—have great
potential to help shape global health. Still, while these countries may be
emerging economically, their public health and health care systems do not
necessarily match their economic advancements. Many aspects of these
systems still need development, and emerging countries will require
assistance and support from the industrialized world.

226. See supra section II, sub-section F.
227. Margaret Chan et al., Foreign Policy and Global Public Health: Working Together
Towards Common Goals, 86 BULL. WORLD HEALTH ORG. 498, 498 (2008).
228. Id.
229. Id.
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Numerous health challenges confront these countries. For example,
Brazil’s HIV/AIDS response is a salient public health success, but gaps exist
even there due to insufficient resources.230 It is “not uncommon” to find
untreated HIV patients in Rio emergency rooms,231 and drugs are not always
available in Brazilian pharmacies, leading citizens to sue the government for
drug access.232 Brazil’s tuberculosis control program is also much less
successful than its HIV/AIDS effort.233
Russia’s health outcomes have been suffering under the post-Soviet
decentralization of the public health system, but, in addition, it is
experiencing a rapid and significant increase in alcohol and substance
abuse. Per capita alcohol consumption in Russia more than doubled
between 1987 and 2001, from about five liters a person to more than
ten.234 In 2006, Russia had over 300,000 registered drug dependents, and
experienced more than 240,000 drug-related crimes, up twenty-three
percent from 2005.235 Both alcohol and substance abuse put individuals at
risk for physical health problems such as tuberculosis, hepatitis, HIV/AIDS,
and other sexually transmitted diseases,236 and more generally, mental
health disorders237 and injuries from auto accidents.238 Russia has one of
the world’s fastest growing HIV epidemics and accounts for the bulk of HIV
cases in Eastern Europe and Central Asia.239

230. Cohen, supra note 24, at 485 (discussing increases in costs and fears about the longterm sustainability of the program).
231. Id. at 486.
232. João Biehl et al., Judicialisation of the Right to Health in Brazil, 373 LANCET 2182,
2182-83 (2009) (discussing the attitudes in Brazil and its legal system toward these lawsuits).
233. Cohen, supra note 24, at 486.
234. WORLD HEALTH ORG., WHO GLOBAL STATUS REPORT ON ALCOHOL 2004, COUNTRY
PROFILES: EUROPEAN REGION: THE RUSSIAN FEDERATION 1 (2004), available at http://www.who.
int/substance_abuse/publications/en/russian_federation.pdf.
235. UNITED NATIONS OFFICE ON DRUGS & CRIME, REG’L OFFICE FOR RUSSIA & BELARUS,
ILLICIT DRUG TRENDS IN THE RUSSIAN FEDERATION 10, 19 (2008), available at http://www.un
odc.org/documents/regional/central-asia/Illicit%20Drug%20Trends%20Report_Russia.pdf.
236. NAT’L INST. ON DRUG ABUSE, DRUG ABUSE AND THE LINK TO HIV/AIDS AND OTHER
INFECTIOUS DISEASES 3 (2008), available at http://www.nida.nih.gov/PDF/Infofacts/DrugsAIDS
08.pdf .
237. Joanna Saisan et al., Substance Abuse and Mental Health: Overcoming Alcohol and
Drug Addiction While Coping with Depression or Anxiety, HELPGUIDE.ORG (2010),
http://www.helpguide.org/mental/dualdiagnosis.htm (defining “co-occurring” disorders as the
condition when an individual has a mental health disorder coupled with a drug or alcohol
problem).
238. See, e.g., Jennifer Copley, Alcohol and Health Problems, Drinking Increases the Risk
for Cancer, Osteoporosis and Injury, SUITE101.COM (2008), http://food-facts.suite101.com/
article.cfm/alcohol_and_health_problems (explaining that motor skill impairment caused by
alcohol consumption makes people more accident-prone and injuries more severe).
239. MORRISON AND KATES, supra note 4, at 10.
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India has a relatively low national HIV/AIDS prevalence rate—about
0.3% in 2008240—but the sheer size of its population means that even at
this rate, India has the world’s third largest number of people living with
HIV/AIDS.241 Even small upward movements in the prevalence rate would
mean big increases in the number of patients and in the demand on India’s
health system.242 More revealing of India’s health system weaknesses is its
high maternal mortality rate, estimated by UNICEF at around 450 per
100,000 live births,243 compared to China’s rate of about fifty per 100,000
live births.244 Major causes for such a high rate include the lack of primary
healthcare facilities, the dearth of skilled birth attendants, corrupt health
workers who extort women for money or withhold care, and the prevalence
of anemia among women due to poor nutrition.245
Inadequate human and physical resources hamper China’s HIV/AIDS
response. Local governments are responsible for implementing and funding
patient treatment, but resources are limited and local officials may have
incentive to downplay the HIV issue for fear of deterring investments.246 A
lack of qualified teachers and education materials likewise undermines HIV
education efforts.247 As the largest producer and consumer of tobacco in
the world, China has over 320 million smokers, or about a third of all
smokers worldwide.248 Between 1980 and 1990, tobacco consumption
increased by 7.2% per year, mainly from new teenage smokers.249 This
poses significant health problems: predicted deaths attributed to smoking
are expected to reach three million in 2050; over two-thirds of smoking-

240. AVERT.org, Overview of HIV and AIDS in India, http://www.avert.org/aidsindia.htm
(last visited Sep. 7, 2010).
241. Id.
242. Id. (noting that an increase in the prevalence of HIV in India by 0.1% would likely
increase the number of individuals living with HIV by over a half million).
243. Sujoy Dhar, India Grapples with High Maternal Death Rate, REUTERS, Jan. 26, 2009,
http://in.reuters.com/article/topNews/idINIndia-37651720090126?pageNumber=1&virtual
BrandChannel=0 (last visited Sep. 7, 2010).
244. Id.
245. See generally id. (detailing how poor women in rural India have been left behind by
India’s economic boom, such that about 78,000 mothers die in India each year from
childbirth and pregnancy).
246. See generally Avert.org, HIV & AIDS in China, http://www.avert.org/aidschina.htm
(last visited Sep. 7, 2010) (describing China’s changed response to the AIDS epidemic as
reflected by the initiation of a program to address the issue); Bates Gill & Susan Okie, China
and HIV – A Window of Opportunity, 356 N ENGL J MED. 1801 (2007); Jonathan Watts, AIDS
in China: New Legislation, Old Doubts, 367 LANCET 803 (2006).
247. HIV & AIDS in China, supra note 247.
248. Hong Zhang & Baiqiang Cai, The Impact of Tobacco on Lung Health in China, 8
RESPIROLOGY 17, 17 (2003).
249. Id. at 17, 18.
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related deaths are due to respiratory conditions such as chronic obstructive
pulmonary disease, lung cancer, and tuberculosis.250
South Africa continues its struggle with HIV/AIDS. It has “the largest
[ART] program in the world,” but also “the world’s largest epidemic.”251
Less than a third of the infected population received treatment in 2007.252
Efforts to prevent mother-to-child transmission are unsatisfactory, with South
Africa’s 2008 guidelines criticized as being below WHO standards.253
Education campaigns are failing due to lack of teachers and the lack of
incentive for teachers to train, with the result of widespread ignorance of
preventive methods.254 Less than half of the South African population,
across all age groups and sexes, were aware of the preventive effects of
condom use and fewer sex partners.255

B.

Still Needed: Assistance from the Global Community

The alarming health problems facing BRIC and their still-developing
health systems make clear their need for continuing assistance from the
global health community. Attention should focus especially on public health
surveillance and control of infectious agents, and on health system
development.
The case of SARS exposed significant gaps in the Chinese public health
surveillance system, specifically its design and vulnerability to political
considerations.
The inefficient reporting process resulted in disease
information passing sequentially through local, provincial, and central levels
of authority before reaching officials who had the power to act.256 “Top
secret” designation for such information precluded interprovincial
information sharing until the Ministry of Health gave permission.257 Personal
and political incentives further limited information flow as various officials
suppressed news of the SARS outbreak to protect trade and investments, to

250. Id. at 18.
251. AVERT.org, HIV and AIDS in South Africa, http://www.avert.org/aidssouthafrica.htm
(last visited Sep. 7, 2010).
252. Id. (reporting that the percent of individuals receiving treatment for HIV in South Africa
is lower than the average in lower- and middle-income countries).
253. Id.
254. Id.
255. Id.
256. Yanzhong Huang, The SARS Epidemic and Its Aftermath in China: A Political
Perspective, in LEARNING FROM SARS: PREPARING FOR THE NEXT DISEASE OUTBREAK 116, 118
(Stacey Knobler et al. eds., 2004), available at http://www.nap.edu/openbook.php?record_id
=10915; see also Amena Ahmad et al., Controlling SARS: A Review on China’s Response
Compared with Other SARS-Affected Countries, 14 TROPICAL MED. & INT’L HEALTH 36, 42
(2009, Suppl. 1).
257. Huang, supra note 257, at 120.
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shield the image of the Chinese Communist Party, and to maintain social
stability.258 Chinese delays in reporting the disease were such that WHO
publicly criticized China as uncooperative in April 2003.259
The SARS episode shows that emerging countries still need assistance
from global health institutions for the necessary resources and technical
oversight in disease surveillance, reporting, and monitoring. International
normative pressure may also help increase media access and spur a more
open and transparent outbreak response. Indeed, in the international
fallout from its SARS response, China—and any other country that was
paying attention—could see that inadequate outbreak response could cause
more economic and reputational damage than the outbreak itself. Its
response to H1N1 was accordingly much more public and aggressive.260
The global health community, especially international organizations such as
WHO, has a convincing rationale for working with emerging and
developing countries to ensure the best possible outcomes from infectious
disease outbreaks.
Health system development also calls for continuing international
assistance. As discussed in the previous section, all the BRIC nations have
health systems suffering at least from insufficient resources and at worst from
near collapse, in the case of Russia. Help is critical to repair and develop
these systems, all of which face daunting challenges including HIV/AIDS, a
focal issue in global health. Screening and treatment programs need to
improve and expand. For example, about a quarter of Chinese respondents
in a 2008 survey did not know where they could get tested for HIV/AIDS.261
Access to antiretroviral treatment was available to only six to fifteen percent
of Russian AIDS sufferers in 2006,262 and to about nineteen percent of
Chinese AIDS patients in 2007.263 Stigma and discrimination against AIDS
sufferers and sometimes even official intolerance of high-risk groups—
especially intravenous drug users—must be reduced to enable better
outreach and treatment. BRIC already receive funds from global donors

258. Id. at 119 (explaining that “the overwhelmingly important issue for China is stability,
without which nothing can be achieved”); Jennifer Prah Ruger, Democracy and Health, 98
Q.J. MED. 299 (2005).
259. Thomas Crampton, WHO Criticizes China Over Handling of Mystery Disease, INT’L
HERALD TRIB., Apr. 7, 2003.
260. Yanzhong Huang, The H1N1 Virus: Varied Local Responses to a Global Spread,
YALEGLOBAL ONLINE, Sep. 1, 2009, http://yaleglobal.yale.edu/content/h1n1-virus-variedlocal-responses-global-spread (proclaiming that, despite its “lackadaisical” and “secretive”
approach during the SARS crisis, at the time of the H1N1 threats, China enacted stringent
quarantine measures as if they were a “silver bullet for all infectious diseases”).
261. HIV & AIDS in China, supra note 247.
262. MORRISON & KATES, supra note 4, at 13.
263. HIV & AIDS in China, supra note 247.
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such as the World Bank, the Global Fund, and the Gates Foundation for
their HIV/AIDS programs; the need endures.
HIV/AIDS touches on other aspects of health systems too. Blood
collection and blood supply must become safe and secure, in light of mass
infections of Chinese blood and plasma donors and recipients through
unsafe practices.264 Quality control for drug and health products must
improve. Almost 44 percent of Chinese condoms tested failed key
requirements, according to a 2001 government survey,265 and the quality of
active drug ingredients manufactured by Indian and Chinese companies are
not always reliable.266 Financial and technical assistance from the global
health community would benefit efforts to address these issues.
International norms and pressure may also help ensure that HIV/AIDS
programs are consistent with human rights. There are concerns, for
instance, about the involuntary nature of HIV testing conducted in Chinese
and Indian hospitals, and about the repression of NGO advocacy in
China.267 It is not clear, however, how effective human rights efforts would
be in China, given its unwillingness to engage these issues.
Non-communicable diseases affect developing countries as they
increasingly experience the health threats typical of more developed
societies. Almost sixty percent of global deaths and close to half of the
global disease burden are due to non-communicable, diet- and inactivityrelated conditions like heart disease, cancer, diabetes, and obesity268; sixtysix percent of those deaths occur in developing countries.269 Control efforts
must address globalized food trade, agricultural policy, and regulations on
marketing, labeling, and ingredients. The WHO developed a 2004 Global
Strategy for Diet, Health, and Physical Activity to help prevent and control
non-communicable diseases,270 but the global community must take further
steps, which may include working with WTO and other relevant entities to
264. Id. (explaining that since the mid 1990s, the safety of China’s blood supply has been
improved by shuttering illegal blood collection agencies and disallowing the most hazardous
practices.)
265. Z.X. Wang et al., The Best Defense – Improving Condom Quality in China (abstract
number: MoPeE4254). Meeting abstract for the 15th International Conference on AIDS, July
11-16, 2004, Bangkok, Thailand, available at: http://gateway.nlm.nih.gov/MeetingAbstracts/
ma?f=102280534.html.
266. Cohen, supra note 24, at 487.
267. HIV & AIDS in China, supra note 247; HIV & AIDS in India, supra note 241 (stating
that although voluntary testing is officially supported in India, some states have implemented
standards that would require people to be tested for HIV against their will).
268. Emily Lee, The World Health Organization’s Global Strategy on Diet, Physical Activity,
and Health: Turning Strategy into Action, 60 FOOD & DRUG L.J. 569, 571 (2005).
269. Id.
270. Id. at 569 (explaining that the Global Strategy is a “nonbinding blueprint” that
countries can use in fighting obesity and other diet- and inactivity-related diseases).
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coordinate a coherent response to this emerging but neglected global
health threat.
Aside from disease surveillance and health system development, the
global health community must work with emerging countries to help address
the bioterrorism threat. Preventing, detecting, and countering bioterrorism is
“extremely difficult,” as biological weapons can be cheaply made from
Internet recipes by those with basic biology and engineering training.271 But
steps can be taken to limit the risks arising from poor monitoring and
control of deadly pathogens. Of prominent concern are repositories like
Vector, which used to be Russia’s major bioweapons facility.272 Up until the
early 1990s, this previously well-guarded, well-equipped compound housed
the only other stock of smallpox virus outside the United States Centers for
Disease Control and Prevention in Atlanta; it also housed hemorrhagic fever
viruses like Ebola and Crimean-Congo.273 Less than a decade after the fall
of the Soviet Union, Vector was “half-empty” and patrolled by “a handful of
guards who had not been paid for months.”274 Russia—and other countries
with stocks of dangerous pathogens—must tighten protection and
monitoring, and the global community should assist financially and
technically, as well as organize a more coordinated global strategy to deal
with bioterrorism.
IV. CONCLUSION
This article describes the roles that emerging countries play in global
health, as the givers and recipients of aid. It outlines the types of assistance
emerging countries can render to less developed states, as well as the sort
of help emerging countries still need from the global health community. We
also contemplate the effect of their participation in global health
governance and their influence on health and foreign policy. Emerging
countries—especially the incipient world powers Brazil, Russia, India, and
China—are in an interesting position. Their still-transforming economies
and health systems connect them directly to the concerns of the developing
world, while their growing economic and political clout give them a place at
the table with industrialized countries and a more powerful voice in global
affairs. The emergence of the BRIC countries as global health actors may
direct greater attention to the needs and perspectives of developing
countries. With appropriate accommodation and effective coordination,
271. D.A. Henderson, Bioterrorism as a Public Health Threat, 4 EMERGING INFECTIOUS
DISEASES 488, 489 (1998), available at http://ftp.cdc.gov/pub/EID/vol4no3/adobe/hender
son.pdf.
272. Id. at 488.
273. Id.
274. Id.
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their expanding role on the world stage should be a positive development
for global public health.
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